|
[1]
|
World Health Organization (2024) Noncommunicable Diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
|
|
[2]
|
World Health Organization (2023) Global Report on Hypertension: The Race Against a Silent Killer. World Health Organization.
|
|
[3]
|
International Diabetes Federation (2021) Diabetes Atlas. https://diabetesatlas.org/
|
|
[4]
|
World Health Organization (2016) Global Report on Diabetes. World Health Organization. https://www.who.int/publications/i/item/9789241565257
|
|
[5]
|
Philips, J.-C. and Radermecker, R. (2012) Type 1 Diabetes: From Genetic Predispo-sition to a Hypothetical Environmental Context. Revue Médicale de Liège, 67, 319-325. (In French)
|
|
[6]
|
Nepom, G.T. and Kwok, W.W. (1998) Molecular Basis for HLA-DQ Associations with IDDM. Diabetes, 47, 1177-1184.[CrossRef] [PubMed]
|
|
[7]
|
Polychronakos, C. (2008) Du nouveau dans la génétique du diabète de type 2. Médecine/Sciences, 24, 241-242.[CrossRef] [PubMed]
|
|
[8]
|
Meulebrouck, S. (2021) Impact of Rare Genetic Variants on the Etiology of Type 2 Diabetes. Ph.D. Thesis, University of Lille.
|
|
[9]
|
Ehret, G.B. and Caulfield, M.J. (2013) Genes for Blood Pressure: An Opportunity to Understand Hypertension. European Heart Journal, 34, 951-961.[CrossRef] [PubMed]
|
|
[10]
|
Patel, R.S., Masi, S. and Taddei, S. (2017) Understanding the Role of Genetics in Hypertension. European Heart Journal, 38, 2309-2312.[CrossRef] [PubMed]
|
|
[11]
|
Jeunemaitre, X. and Gimenez-Roqueplo, A. (2002) Génétique et hypertension artérielle: Trois approches pour décrypter une maladie complexe. Bulletin de l’Académie Nationale de Médecine, 186, 1595-1609.[CrossRef] [PubMed]
|
|
[12]
|
van Rijn, M.J.E., Schut, A.F., Aulchenko, Y.S., Deinum, J., Sayed-Tabatabaei, F.A., Yazdanpanah, M., et al. (2007) Heritability of Blood Pressure Traits and the Genetic Contribution to Blood Pressure Variance Explained by Four Blood-Pressure-Related Genes. Journal of Hypertension, 25, 565-570.[CrossRef] [PubMed]
|
|
[13]
|
Scheen, A., Paquot, N. and Bauduceau, B. (2014) Diabetes in the Elderly: From Epidemiological Challenge to a Personalized Approach. Revue Médicale de Liège, 69, 323-328. (In French)
|
|
[14]
|
Rigalleau, V., Lang, J. and Gin, H. (2007) Étiologie et physiopathologie du diabète de type 2. EMC—Endocrinologie-Nutrition, 18, 1-12.[CrossRef]
|
|
[15]
|
Siagh Malak, H. and Boukhalfa, R. (2022) Epidemiological and Evolutionary Profile of Diabetes in the Internal Medicine Department of Mohammed Boudiaf EPH, Ouargla during the Year 2022. Ph.D. Thesis, Kasdi Merbah University.
|
|
[16]
|
Boulefred, A., Dembélé Amadou, I., Amadou, N., Traoré, A.K., Benlatreche, R., Rosunee, A., et al. (2021) Focus on Type 2 Diabetes in the Elderly. Cahiers Santé Médecine Thérapeutique, 30, 232-249.[CrossRef]
|
|
[17]
|
Yayehd, K., Damorou, F., Akakpo, R., Tchérou, T., N’Da, N.W., Pessinaba, S., et al. (2013) Prévalence de l’hypertension artérielle et description de ses facteurs de risque à Lomé (Togo): Résultats d’un dépistage réalisé dans la population générale en mai 2011. Annales de Cardiologie et d’Angéiologie, 62, 43-50.[CrossRef] [PubMed]
|
|
[18]
|
Panda, J.L.K., Masumbuko, J.L. and Mairiaux, P. (2020) Prévalence de l’hypertension artérielle et les facteurs de risques en milieu professionnel en République démocratique du Congo: Cas de la société textile de Kisangani. Ethics, Medicine and Public Health, 15, Article 100581.[CrossRef]
|
|
[19]
|
Cheng, W., Du, Y., Zhang, Q., Wang, X., He, C., He, J., et al. (2022) Age-Related Changes in the Risk of High Blood Pressure. Frontiers in Cardiovascular Medicine, 9, 1-10.[CrossRef] [PubMed]
|
|
[20]
|
DeGuire, J., Clarke, J., Rouleau, K., Roy, J. and Bushnik, T. (2019) Blood Pressure and Hypertension. Health Reports, 30, 14-21. https://www.researchgate.net/profile/Tracey-Bushnik/publication/331440009_Blood_pressure_and_hypertension/links/5c87c5ee299bf1e02e29b513/Blood-pressure-and-hypertension.pdf
|
|
[21]
|
Rorive, M., Letiexhe, M., Scheen, A. and Ziegler, O. (2005) Obésité et diabète de type 2. Revue Médicale de Liège, 60, 374-382.
|
|
[22]
|
Vivot, K. (2012) Identification of the Cellular and Molecular Mechanisms Underlying the Early Loss of Pancreatic Islets during Transplantation. Ph.D. Thesis, University of Strasbourg.
|
|
[23]
|
Scheen, A.J. (2014) De l’obésité au diabète de type 2: Interrelations entre insulino-resistance et altération de la secrétion d’insuline. https://www.egeaconference.com/wp-content/uploads/2018/01/livre_resume_2004_FR.pdf#page=14
|
|
[24]
|
Zaamouche, A., Lakhal, A., Benlatreche, C., Mehdioui, H. and Roula, D. (2013) Obésité et diabète type 2: L’obésité morbide est-elle protectrice contre le diabète de type 2? Diabetes & Metabolism, 39, A120.[CrossRef]
|
|
[25]
|
Konan, Y.E., Tetchi, E.O., Ekou, F.K. and Gilbert, L. (2023) Profil des diabetiques de 20 ans a 79 ans de l’enquete nationale sur la prevalence et caracteristiques du diabete en Côte d’Ivoire. Revue Africaine des Sciences Sociales Et De La Santé Publique, 5, 311-321.
|
|
[26]
|
Diaga, M. (2020) Epidemiological-Clinical Profile of the Newly Diagnosed Diabetic Patient at the Center for the Fight against Diabetes. Ph.D. Thesis, University of Sciences, Techniques and Technologies of Bamako (USTTB).
|
|
[27]
|
Burnier, M. and Taddei, S. (2004) Traitement de l’hypertension chez les patients obèses: Quelle approche thérapeutique choisir? Revue Médicale Suisse, 62, 1723-1732.[CrossRef]
|
|
[28]
|
Ramos-Arellano, L.E., Matia-Garcia, I., Marino-Ortega, L.A., Castro-Alarcón, N., Muñoz-Valle, J.F., Salgado-Goytia, L., et al. (2020) Obesity, Dyslipidemia, and High Blood Pressure Are Associated with Cardiovascular Risk, Determined Using High-Sensitivity C-Reactive Protein Concentration, in Young Adults. Journal of International Medical Research, 48, 1-12.[CrossRef] [PubMed]
|
|
[29]
|
Kusuayi Mabele, G., Nkiama Ekisawa, C., Delecluse, C., Lepira Bompeka, F. and NkodilaNatuhoyila, A. (2018) Évaluation de la prévalence de l’hypertension artérielle de l’adulte en milieu du travail à Kinshasa, République Démocratique du Congo. Science & Sports, 33, 213-220.[CrossRef]
|
|
[30]
|
Koffi, N.M., Sally, S.J., Kouame, P., Silue, K. and Nama, A.D. (2001) Profile of Arterial Hypertension in the Workplace in Abidjan. Médecine d’Afrique Noire, 48, 257-260.
|
|
[31]
|
Thiombiano, L.P., Mbaye, A., Sarr, S.A., Ngaide, A.A., Kane, A., Diao, M., et al. (2016) Prévalence de la dyslipidémie dans la population rurale de Guéoul (Sénégal). Annales de Cardiologie et d’Angéiologie, 65, 77-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Tanguy, B. and Aboyans, V. (2014) Dyslipidémie et diabète. Revues Générales Métabolisme, 303, 37-41. https://www.realites-cardiologiques.com/wp-content/uploads/sites/2/2014/11/09.pdf
|
|
[33]
|
Vergès, B. (2019) Physiopathologie de la dyslipidémie du diabète de type 2: Nouvelles perspectives. Médecine des Maladies Métaboliques, 13, 140-146.[CrossRef]
|
|
[34]
|
Diom, M., Hakim, R., Diagne, D., Kane, M., Ndour, M., Diao, M., Diallo, A., et al. (2010) Profil lipidique et risque cardio-vasculaire du diabétique de type 2 au Sénégal. Angéiologie, 62, 25-29. https://www.researchgate.net/profile/Alassane-Mbaye-2/publication/288814292_Lipid_profile_and_cardiovascular_risk_of_type_2_diabetic_in_Senegal/links/5708e27d08ae8883a1fa4ad3/Lipid-profile-and-cardiovascular-risk-of-type-2-diabetic-in-Senegal.pdf
|
|
[35]
|
Jacobsen, A.P., Whelton, S.P., Blumenthal, R.S. and Mcevoy, J.W. (2024) Dyslipidemia. In: Bakris, G.L., Sorrentino, M.J. and Laffin, L.J., Eds., Hypertension, Elsevier, 476-488.[CrossRef]
|
|
[36]
|
Jin, E.-S., Shim, J.-S., Kim, S. E., Bae, J. H., Kang, S., Won, J. C., Shin, M.-J., et al. (2023) Dyslipidemia Fact Sheet in South Korea, 2022. Diabetes & Metabolism Journal, 47, 632-642.[CrossRef] [PubMed]
|
|
[37]
|
Tang, N., Ma, J., Tao, R., Chen, Z., Yang, Y., He, Q., et al. (2022) The Effects of the Interaction between BMI and Dyslipidemia on Hypertension in Adults. Scientific Reports, 12, 1-7.[CrossRef] [PubMed]
|
|
[38]
|
Mossavarali, S., Azizpour, Y., Golestani, A., Rezaei, N., Khosravi, S., Mirzad, M., et al. (2025) Prevalence of Dyslipidemia and Its Association with Blood Pressure Control in Iranian Hypertensive Patients: Insights from STEPS 2021. Lipids in Health and Disease, 24, 1-17.[CrossRef] [PubMed]
|
|
[39]
|
Obsa, M.S., Ataro, G., Awoke, N., Jemal, B., Tilahun, T., Ayalew, N., et al. (2022) Determinants of Dyslipidemia in Africa: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine, 8, 1-13.[CrossRef] [PubMed]
|
|
[40]
|
Ojji, D.B., Ajayi, S.O., Mamven, M.H. and Atherton, J. (2009) Prevalence of Dyslipidemia in Normoglycemic Subjects with Newly Diagnosed High Blood Pressure in Abuja, Nigeria. Journal of Clinical Lipidology, 3, 51-56.[CrossRef] [PubMed]
|
|
[41]
|
Wyszyńska, J., Łuszczki, E., Sobek, G., Mazur, A. and Dereń, K. (2023) Association and Risk Factors for Hypertension and Dyslipidemia in Young Adults from Poland. International Journal of Environmental Research and Public Health, 20, Article 982.[CrossRef] [PubMed]
|
|
[42]
|
Spannella, F., Giulietti, F., Di Pentima, C. and Sarzani, R. (2019) Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese. Advances in Therapy, 36, 1426-1437.[CrossRef] [PubMed]
|
|
[43]
|
Coulibaly, S. (2021) Evaluation of the Nutritional Status and Behavioral Factors of Diabetic Patients. Ph.D. Thesis, University of Sciences, Techniques and Technologies of Bamako (USTTB).
|
|
[44]
|
Sigal, R.J., Armstrong, M.J., Bacon, S.L., Boulé, N.G., Dasgupta, K., Kenny, G.P., et al. (2018) Physical Activity and Diabetes. Canadian Journal of Diabetes, 42, S54-S63.[CrossRef] [PubMed]
|
|
[45]
|
Sawadogo, N., Garanet, F., Ouédraogo, S., Ouédraogo, W.M.E., Zoungrana, H., Ouoba, P.C. and Cissé, A. (2023) Depistage du diabete et des autres facteurs de risque cardiovasculaire dans la ville de ouahigouya au burkina faso. Dakar Médical, 67, 164-170. https://dakarmedical.org/dkmed/index.php/dakarmed/article/view/69
|
|
[46]
|
Pinto, A.J., Bergouignan, A., Dempsey, P.C., Roschel, H., Owen, N., Gualano, B., et al. (2023) Physiology of Sedentary Behavior. Physiological Reviews, 103, 2561-2622.[CrossRef] [PubMed]
|
|
[47]
|
Krzesinski, J.-M. and Saint-Remy, A. (2012) Les maladies complexes: L’hypertension artérielle. Revue Médicale de Liège, 67, 279-285.
|
|
[48]
|
Taleb, A., Cherif, A.B., Debih, N.D., Bouamra, A. and Bouafia, M.T. (2020) The Status of Arterial Hypertension among Nomads in Southern Algeria. Journal de la Faculté de Médecine de Blida, 7, 4-5.
|
|
[49]
|
Léonard, L.L., Odilon, N.B., Armand, K., Léopold, I., Kafack, E.V.F. and Ngongang, A.D. (2024) Hypertension in Black African Subjects: A Study of 233 Central African subjects. Health Sciences and Disease, 25, 44-48. https://hsd-fmsb.org/index.php/hsd/article/view/5879
|
|
[50]
|
Yahia, F., Ba, F., Camara, S., Kane, A., Sarr, S.A., Abderahmane, M.L., Elghazaly, A., et al. (2019) Epidemiological, Clinical, and Evolutionary Aspects of Hypertension in the Elderly in Nouakchott (Mauritania). La Tunisie Médicale, 97, 1219-1224.
|
|
[51]
|
Lee, P.H. and Wong, F.K.Y. (2015) The Association between Time Spent in Sedentary Behaviors and Blood Pressure: A Systematic Review and Meta-Analysis. Sports Medicine, 45, 867-880.[CrossRef] [PubMed]
|
|
[52]
|
Paterson, C., Fryer, S., Stone, K., Zieff, G., Turner, L. and Stoner, L. (2021) The Effects of Acute Exposure to Prolonged Sitting, with and without Interruption, on Peripheral Blood Pressure among Adults: A Systematic Review and Meta-Analysis. Sports Medicine, 52, 1369-1383.[CrossRef] [PubMed]
|
|
[53]
|
Engler, P.A., Ramsey, S.E. and Smith, R.J. (2010) Alcohol Use of Diabetes Patients: The Need for Assessment and Intervention. Acta Diabetologica, 50, 93-99.[CrossRef] [PubMed]
|
|
[54]
|
Clerc, O.F. (2011) Alcohol Consumption, Metabolic Syndrome, and Diabetes in a Population with High Average Alcohol Consumption. Ph.D. Thesis, University of Lausanne, Faculty of Biology and Medicine.
|
|
[55]
|
Magis, D., Jandrain, B. and Scheen, A. (2003) Alcohol, Insulin Sensitivity, and Diabetes Mellitus. Revue Médicale de Liège, 58, 501-507. (In French)
|
|
[56]
|
Schlienger, J.L., Pradignac, A. and Vinzio, S. (2008) Alcool, métabolisme glucidique et diabète. Sang Thrombose Vaisseaux, 20, 8-13. https://www.jle.com/fr/revues/stv/doc/alcool-metabolisme-glucidique-et-diabete_26355/jle_article.dhtml
|
|
[57]
|
Cullmann, M., Hilding, A. and Östenson, C. (2012) Alcohol Consumption and Risk of Pre‐Diabetes and Type 2 Diabetes Development in a Swedish Population. Diabetic Medicine, 29, 441-452.[CrossRef] [PubMed]
|
|
[58]
|
Baliunas, D.O., Taylor, B.J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., et al. (2009) Alcohol as a Risk Factor for Type 2 Diabetes. Diabetes Care, 32, 2123-2132.[CrossRef] [PubMed]
|
|
[59]
|
Clair, C., Cornuz, J. and Berlin, I. (2011) Smoking, Obesity, and Diabetes: A Clinically Important Interaction. Revue Médicale Suisse, 7, 2338-2342.[CrossRef]
|
|
[60]
|
Gruyer, B. and Vergès, B. (2020) Association tabac et diabète de type 2: Preuves et mécanismes physiopathologiques. Médecine des Maladies Métaboliques, 14, 148-151.[CrossRef]
|
|
[61]
|
Thébaut, J., Namur, A., Phirmis, L., Attal, D., Durlach, V., Gautier, J., et al. (2023) Diabète et tabagisme: La fédération française des diabétiques met en lumière ce facteur de risque méconnu. Médecine des Maladies Métaboliques, 17, 141-146.[CrossRef]
|
|
[62]
|
Aarsand, R., Hemmingsen, B., Soweid, L., St Claire, S., Tursan D’Espaignet, E., Hu, F., Schotte, K., et al. (2023) Tobacco and Diabetes: A Summary of Evidence. World Health Organization (WHO). https://iris.who.int/bitstream/handle/10665/375848/9789240088566-fre.pdf?sequence=1
|
|
[63]
|
Thuillier, P. and Mansourati, J. (2023) Quels sont les liens entre tabagisme et insulinorésistance, insulinosensibilité? Médecine des Maladies Métaboliques, 17, 108-116.[CrossRef]
|
|
[64]
|
Al-Salameh, A., Tramunt, B. and Rouland, A. (2023) Influence du tabagisme sur la mortalité et les complications chez le sujet diabétique. Médecine des Maladies Métaboliques, 17, 117-124.[CrossRef]
|
|
[65]
|
Naassila, M., Bouajila, N., Thomas, D. and Aubin, H.-J. (2023) Alcohol Consumption and Arterial Hypertension. Alcoologie et Addictologie, 73, 661-668.
|
|
[66]
|
Zamora-Kapoor, A., Hebert, L., Mellacheruvu, P., Buchwald, D. and Sinclair, K. (2024) Mediation of Risk Factors for High Blood Pressure in Four Racial and Ethnic Populations. Longitudinal and Life Course Studies, 15, 478-491.[CrossRef] [PubMed]
|
|
[67]
|
Bealoum, R.E. (2023) Complications of Arterial Hypertension in Elderly Patients at the Peace Hospital of Ziguinchor (A Retrospective Study of 102 Cases). Ph.D. Thesis, University of Ziguinchor.
|
|
[68]
|
Zohra, M.F., Marwa, M.I.E.M.S. and Abi Iyad, M. (2022) The Effect of Diet on Type 2 Diabetes (A Systematic Study). Master’s Thesis, University of Tlemcen.
|
|
[69]
|
Féry, F. and Paquot, N. (2005) Etiopathogenesis and Pathophysiology of Type 2 Diabetes. Revue Médicale de Liège, 60, 361-368. (In French)
|
|
[70]
|
Hermier, D. (2010) Impact métabolique des acides gras saturés/insaturés. Innovations Agronomiques, 10, 11-23. https://hal.science/hal-01186795/
|
|
[71]
|
Duquenne, P., Fezeu, L.K., Bourhis, L., Yvroud, P., Srour, B., Kesse-Guyot, E., et al. (2025) Facteurs de risque d’origine nutritionnelle du diabète de type 2—Apport de la cohorte française NutriNet-Santé aux connaissances scientifiques. Cahiers de Nutrition et de Diététique, 60, 164-175.[CrossRef]
|
|
[72]
|
Mahjoub, F., Moalla, H., Ben Amor, N., Souissi, N., Jendoubi, H., Lahmer, I., et al. (2021) Profil nutritionnel des diabétiques de type 2 hospitalisés. Annales d’Endocrinologie, 82, Article 505.[CrossRef]
|
|
[73]
|
Mangal, D.K., Shaikh, N., Tolani, H., Gautam, D., Pandey, A.K., Sonnathi, Y., et al. (2025) Burden of Micronutrient Deficiency among Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis. BMJ Nutrition, Prevention & Health, 8, 334-344.[CrossRef] [PubMed]
|
|
[74]
|
Stamler, J., Rose, G., Elliott, P., Dyer, A., Marmot, M., Kesteloot, H., et al. (1991) Findings of the International Cooperative INTERSALT Study. Hypertension, 17.[CrossRef] [PubMed]
|
|
[75]
|
Bourel, M. and Ardaillou, R. (2004) Contenu en sel de l’alimentation et hypertension artérielle. Bulletin de l’Académie Nationale de Médecine, 188, 317-329.[CrossRef]
|
|
[76]
|
Uzan, A. and Delaveau, P. (2009) Le sel dans l’alimentation: Un problème de santé publique. Annales Pharmaceutiques Françaises, 67, 291-294.[CrossRef] [PubMed]
|
|
[77]
|
Paquette, G.D.-M.-C. (2018) Sodium in Our Diet: Main Contributors and Modeling the Impact of Sodium Reduction. National Institute of Public Health of Quebec (INSPQ). https://policycommons.net/artifacts/2062562/le-sodium-dans-notre-alimentation/2815653/
|
|
[78]
|
Chatelanat, O., Pechère-Bertschi, A. and Ponte, B. (2019) Sensibilité au sel et hypertension artérielle. Revue Médicale Suisse, 15, 1625-1628.[CrossRef]
|
|
[79]
|
Oparil, S., Acelajado, M.C., Bakris, G.L., Berlowitz, D.R., Cífková, R., Dominiczak, A.F., et al. (2018) Hypertension. Nature Reviews Disease Primers, 4, 1-48.[CrossRef] [PubMed]
|
|
[80]
|
Alaoui, L., Jaonina, M.G. and Keba, N. (2020) Rôles des minéraux (Sodium, Potassium, Calcium et Magnésium) dans la prévention et la prise en charge de l’hypertension artérielle. Revue Marocaine des Sciences Agronomiques et Vétérinaires, 8, 253-257. https://www.agrimaroc.org/index.php/Actes_IAVH2/article/view/818
|
|
[81]
|
Bochud, M., Burnier, M., Marques-Vidal, P. and Paccaud, F. (2010) Réduction De La Consommation De Sel: Une Mesure Importante De Santé Publique En Suisse. Revue Médicale Suisse, 6, 494-498.[CrossRef]
|
|
[82]
|
Berriche, O., Bou Meftah, S., Triki, S., Amrouche, C. and Blouza, S. (2010) P290 Facteurs nutritionnels de l’hypertension artérielle dans une population d’obèses tunisiens. Diabetes & Metabolism, 36, A107.[CrossRef]
|
|
[83]
|
Soubeiga, J.K., Millogo, T., Bicaba, B.W., Doulougou, B. and Kouanda, S. (2017) Prevalence and Factors Associated with Hypertension in Burkina Faso: A Countrywide Cross-Sectional Study. BMC Public Health, 17, Article No. 64.[CrossRef] [PubMed]
|
|
[84]
|
Debras, C., Srour, B., Chazelas, E., Julia, C., Kesse-Guyot, E., Allès, B., et al. (2022) Aliments ultra-transformés, maladies chroniques, et mortalité: Résultats de la cohorte prospective NutriNet-Santé. Cahiers de Nutrition et de Diététique, 57, 222-234.[CrossRef]
|
|
[85]
|
Meghezzi, S. and Ould Lamra, N. (2023) Effects of Ultra-Processed Foods on Health. Master’s Thesis, Mouloud Mammeri University.
|
|
[86]
|
Fardet, A. (2017) Prévention des maladies chroniques: Pour une classification holistique des aliments selon leur degré de transformation. Nutritions & Endocrinologie, 15, 85-88. https://hal.science/hal-01840981/document
|
|
[87]
|
Levy, R.B., Rauber, F., Chang, K., Louzada, M.L.D.C., Monteiro, C.A., Millett, C., et al. (2021) Ultra-Processed Food Consumption and Type 2 Diabetes Incidence: A Prospective Cohort Study. Clinical Nutrition, 40, 3608-3614.[CrossRef] [PubMed]
|
|
[88]
|
Wang, M., Du, X., Huang, W. and Xu, Y. (2022) Ultra-Processed Foods Consumption Increases the Risk of Hypertension in Adults: A Systematic Review and Meta-Analysis. American Journal of Hypertension, 35, 892-901.[CrossRef] [PubMed]
|
|
[89]
|
Nardocci, M., Polsky, J.Y. and Moubarac, J. (2020) Consumption of Ultra-Processed Foods Is Associated with Obesity, Diabetes and Hypertension in Canadian Adults. Canadian Journal of Public Health, 112, 421-429.[CrossRef] [PubMed]
|
|
[90]
|
Lima, R., Moreira, L., Rossato, S., Silva, R. and Fuchs, S. (2011) P2-155 Consumption of Ultra-Processed Food Is Associated with Blood Pressure in Hypertensive Individuals. Journal of Epidemiology and Community Health, 65, A263.3-A263.[CrossRef]
|
|
[91]
|
Scaranni, P.D.O.D.S., Cardoso, L.D.O., Chor, D., Melo, E.C.P., Matos, S.M.A., Giatti, L., et al. (2021) Ultra-Processed Foods, Changes in Blood Pressure and Incidence of Hypertension: The Brazilian Longitudinal Study of Adult Health (Elsa-Brasil). Public Health Nutrition, 24, 3352-3360. [Google Scholar] [CrossRef] [PubMed]
|
|
[92]
|
Golzarand, M., Moslehi, N., Mirmiran, P. and Azizi, F. (2024) Consumption of Ultra-Processed Foods and the Incidence of Hypertension: A Cohort Study. Food & Function, 15, 9488-9496.[CrossRef] [PubMed]
|
|
[93]
|
Schlienger, J.L. and Sauvanet, J.P. (2019) De la Force du sang à l’hypertension artérielle: Naissance d’une maladie-facteur de risque. Médecine des Maladies Métaboliques, 13, 465-471.[CrossRef]
|
|
[94]
|
Monabeka, H.G., Bouenizabila, E. and Etitiele, F. (1998) Arterial Hypertension and Diabetes Mellitus: Regarding 152 Hypertensive Diabetic Patients. Médecine d’Afrique Noire, 42, 105-109.
|
|
[95]
|
Koné, F. (2022) Cardiovascular Comorbidities and Glycemic Control in Type 2 Diabetic Patients Followed at the Reference Health Center (CS Réf) of Commune II: about 100 Cases. Ph.D. Thesis, University of Sciences, Techniques and Technologies of Bamako.
|
|
[96]
|
Ancion, A., Lancellotti, P. and Pierard, L. (2005) Insuffisance cardiaque et diabète. Revue Medicale de Liege, 60, 536-540.
|
|
[97]
|
Moalla, H., Bornaz, E., Souissi, N., Safi, E., Ben Ali, K., Htira, Y., et al. (2021) Hypertension artérielle chez le diabétique: Fréquence et facteurs associés. Annales d’Endocrinologie, 82, Article 532.[CrossRef]
|
|
[98]
|
Scheen, A., Philips, J.-C. and Krzesinski, J.-M. (2012) Hypertension and Diabetes: Regarding a Common but Complex Association. Revue Médicale de Liège, 67, 133-138. (In French)
|
|
[99]
|
Bertal Filali, K., Oulad Sayad, N. and Diouri, A. (2009) P57 Prise en charge de l’HTA chez le diabétique. Diabetes & Metabolism, 35, A42.[CrossRef]
|
|
[100]
|
Ohishi, M. (2018) Hypertension with Diabetes Mellitus: Physiology and Pathology. Hypertension Research, 41, 389-393.[CrossRef] [PubMed]
|
|
[101]
|
Jia, G. and Sowers, J.R. (2021) Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension, 78, 1197-1205.[CrossRef] [PubMed]
|
|
[102]
|
Petrie, J.R., Guzik, T.J. and Touyz, R.M. (2018) Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Canadian Journal of Cardiology, 34, 575-584.[CrossRef] [PubMed]
|
|
[103]
|
Yamazaki, D., Hitomi, H. and Nishiyama, A. (2018) Hypertension with Diabetes Mellitus Complications. Hypertension Research, 41, 147-156.[CrossRef] [PubMed]
|
|
[104]
|
Marassi, M. and Fadini, G.P. (2023) The Cardio-Renal-Metabolic Connection: A Review of the Evidence. Cardiovascular Diabetology, 22, Article No. 195.[CrossRef] [PubMed]
|
|
[105]
|
Hasni, Y., Nouira, S., Elfekih, H., Saad, G., Maaroufi, A., Kacem, M., et al. (2023) L’association HTA-diabète sucré: Quel lien avec les complications dégénératives? Annales d’Endocrinologie, 84, Article 212.[CrossRef]
|
|
[106]
|
Carmoi, T., Verret, C., Debonne, J.M. and Klotz, F. (2007) Management of Type 2 Diabetes in Sub-Saharan Africa: Current Observations and Perspectives. Médecine Tropicale, 67, 601-606. (In French)
|
|
[107]
|
Belkacem, S. (2023) Specific Characteristics of Arterial Hypertension in Diabetic Patients. Algerian Journal of Medical and Health Research, 2, 44-55. https://ajmhr.net/wp-content/uploads/2023/06/4.-Les-particularites-de-lhypertension-arterielle-chez-le-patient-diabetique.pdf
|
|
[108]
|
Krzesinski, J.-M. and Weekers, L. (2005) Hypertension et diabète. Revue Médicale de Liège, 60, 572-577.
|
|
[109]
|
Mbaye, M., Niang, K., Sarr, A., Mbaye, A., Diedhiou, D., Ndao, M., et al. (2011) Aspects épidémiologiques du diabète au Sénégal: Résultats d’une enquête sur les facteurs de risque cardiovasculaire dans la ville de Saint-Louis. Médecine des Maladies Métaboliques, 5, 659-664.[CrossRef]
|
|
[110]
|
Diallo, I.S. (2019) Frequency of Dyslipidemia in Type 2 Diabetic Patients in the In-ternal Medicine Department of Point G University Hospital. Ph.D. Thesis, University of Sciences, Techniques and Technologies of Bamako (USTTB).
|
|
[111]
|
Diallo, A.A.S., Bah, M.L.Y., Barry, M., Balde, N.M. and Sylla, A. (2018) Prevalence of Arterial Hypertension among Diabetic Patients at the Diabetology Unit of the Kindia Regional Hospital. Revue d’Épidémiologie et de Santé Publique, 5, 50-54.
|
|
[112]
|
Sani, M.M., Ada, A., Tchatath, N.N.V., Daou, M., Brah, S., Andia, A., Malam-Abdou, B., et al. (2018) Characteristics of Diabetes in Elderly Patients over 60 Years of Age in Niger. Health Sciences and Disease, 19, 10-14. http://www.hsd-fmsb.org/index.php/hsd/article/view/1015
|
|
[113]
|
Séré, L., Tiéno, H., Yanogo, D., Traoré, S., Nagabila, Y., Ouédraogo, D.D. and Drabo, Y. J. (2021) Prevalence of Diabetes and Associated Cardiovascular Risk Factors in a rural Population in Burkina Faso. Médecine Tropicale et Santé Internationale, 1, B1J8-7K63. (in French)
|
|
[114]
|
Long, A.N. and Dagogo‐Jack, S. (2011) Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection. The Journal of Clinical Hypertension, 13, 244-251.[CrossRef] [PubMed]
|
|
[115]
|
Hurst, C., Thinkhamrop, B. and Tran, H.T. (2015) The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide Cross-Sectional Study in Thailand. Diabetes & Metabolism Journal, 39, 395.[CrossRef] [PubMed]
|
|
[116]
|
Couderc, C. (2021) Curing Type 2 Diabetes Through Diet. Ph.D. Thesis, University of Toulouse.
|
|
[117]
|
Pruijm, M., Wuerzner, G., Forni, V., Bochud, M., Pechere-Bertschi, A. and Burnier, M. (2010) Diet and Hypertension. Revue Médicale Suisse, 6, 1715-1720.[CrossRef]
|
|
[118]
|
Gosse, P. and Bely, H. (2004) Prescription diététique dans l’hypertension artérielle. EMC—Médecine, 1, 37-41.[CrossRef]
|
|
[119]
|
Schlienger, J. (2016) La prise en charge hygiéno-diététique du diabète de type 2: première étape de l’itinéraire. Médecine des Maladies Métaboliques, 10, 101-106.[CrossRef]
|
|
[120]
|
Battu, C. (2014) Prise en charge nutritionnelle d’un adulte présentant une hypertension artérielle. Actualités Pharmaceutiques, 53, 55-58.[CrossRef]
|
|
[121]
|
Blacher, J., Czernichow, S., Iaria, P., Bureau, J., Roux, O., Kondo, T., et al. (2005) Traitement non pharmacologique de l’hypertension artérielle. EMC—Cardiologie-Angéiologie, 2, 136-151.[CrossRef]
|
|
[122]
|
Couch, S.C., Saelens, B.E., Khoury, P.R., Dart, K.B., Hinn, K., Mitsnefes, M.M., et al. (2021) Dietary Approaches to Stop Hypertension Dietary Intervention Improves Blood Pressure and Vascular Health in Youth with Elevated Blood Pressure. Hypertension, 77, 241-251.[CrossRef] [PubMed]
|
|
[123]
|
Cicero, A.F.G., Veronesi, M. and Fogacci, F. (2021) Dietary Intervention to Improve Blood Pressure Control: Beyond Salt Restriction. High Blood Pressure & Cardiovascular Prevention, 28, 547-553.[CrossRef] [PubMed]
|
|
[124]
|
Fardet, A. (2017) L’effet matrice des aliments, un nouveau concept. Pratiques en nutrition, 13, 37-40.[CrossRef]
|
|
[125]
|
Fardet, A. (2019) Que penser des aliments ultra-transformés? Métabolismes Hormones Diabètes et Nutrition, 23, 76-80. https://www.academia.edu/download/59666211/MHDN_2019.pdf
|
|
[126]
|
Amrouche-Rached, C., Gammoudi, A., Ounaissa, K., Kacem, A., Sellami, H. and Blouza-Chabchoub, S. (2009) P210 Facteurs nutritionnels de l’hypertension artérielle dans une population de diabétiques tunisiens. Diabetes & Metabolism, 35, A77.[CrossRef]
|
|
[127]
|
McLean, R.M. and Wang, N.X. (2021) Chapter Three—Potassium. In: Eskin, N.A.M., ed., Advances in Food and Nutrition Research, Academic Press, 89-121. https://www.sciencedirect.com/science/article/pii/S1043452621000188
|
|
[128]
|
Jerôme, C.S. (2021) Prevalence and Determinants of Arterial Hypertension among Adults Aged 25 to 64 in Southwestern Benin. Revue Africaine et Malgache de Recherche Scientifique, 1, 1-10. http://publication.lecames.org/index.php/sante/article/view/831
|
|
[129]
|
Palmer, B.F. and Clegg, D.J. (2020) Blood Pressure Lowering and Potassium Intake. Journal of Human Hypertension, 34, 671-672.[CrossRef] [PubMed]
|
|
[130]
|
Burnier, M. (2018) Should We Eat More Potassium to Better Control Blood Pressure in Hypertension? Nephrology Dialysis Transplantation, 34, 184-193.[CrossRef] [PubMed]
|
|
[131]
|
Binia, A., Jaeger, J., Hu, Y., Singh, A. and Zimmermann, D. (2015) Daily Potassium Intake and Sodium-to-Potassium Ratio in the Reduction of Blood Pressure. Journal of Hypertension, 33, 1509-1520.[CrossRef] [PubMed]
|
|
[132]
|
Noh, H., Park, S., Lee, H., Oh, H., Paek, Y.J., Song, H.J., et al. (2015) Association between High Blood Pressure and Intakes of Sodium and Potassium among Korean Adults: Korean National Health and Nutrition Examination Survey, 2007-2012. Journal of the Academy of Nutrition and Dietetics, 115, 1950-1957.[CrossRef] [PubMed]
|
|
[133]
|
World Health Organization (2012) Guideline: Potassium Intake for Adults and Children. World Health Organization. https://iris.who.int/handle/10665/77986
|
|
[134]
|
Zemel, M.B. (2001) Calcium Modulation of Hypertension and Obesity: Mechanisms and Implications. Journal of the American College of Nutrition, 20, 428S-435S.[CrossRef] [PubMed]
|
|
[135]
|
Loret-Vanhoutte, E. (2013) Nutritional Management of the Hypertensive Patient. Ph.D. Thesis, Joseph Fourier University.
|
|
[136]
|
Villa-Etchegoyen, C., Lombarte, M., Matamoros, N., Belizán, J.M. and Cormick, G. (2019) Mechanisms Involved in the Relationship between Low Calcium Intake and High Blood Pressure. Nutrients, 11, Article 1112.[CrossRef] [PubMed]
|
|
[137]
|
van Mierlo, L.A.J., Arends, L.R., Streppel, M.T., Zeegers, M.P.A., Kok, F.J., Grobbee, D.E., et al. (2006) Blood Pressure Response to Calcium Supplementation: A Meta-Analysis of Randomized Controlled Trials. Journal of Human Hypertension, 20, 571-580.[CrossRef] [PubMed]
|
|
[138]
|
Lelong, H. (2017) Relationship between Non-Pharmacological Measures and Blood Pressure: Analysis of Data from the NutriNet-Santé Study. Ph.D. Thesis, Sorbonne Paris Cité University.
|
|
[139]
|
Guessous, I. and Bochud, M. (2012) Effects of Calcium and Vitamin D Supplemen-tation on Cardiovascular Disease. Revue Médicale Suisse, 8, 1458-1463.[CrossRef]
|
|
[140]
|
Minetto, D., Serratrice, J. and Stirnemann, J. (2016) Le magnesium dans la pratique clinique quotidienne. Revue Médicale Suisse, 12, 1761-1765.[CrossRef]
|
|
[141]
|
Djenebou, T. and Djeneba Sylla, S.O.W. (2021) Magnesium profile in type 2 dia-betics. Revue Internationale des Sciences Médicales d’Abidjan, 23, 187-191. https://www.revues-ufhb-ci.org/fichiers/FICHIR_ARTICLE_3190.pdf
|
|
[142]
|
Djouadi, L., Zazoua, H.A., Rouabah, R. and Bounar, K. (2018) Magnesium and Type 2 Diabetes. Ph.D. Thesis, Constantine 3 Salah Boubnider University, Faculty of Medicine.
|
|
[143]
|
Bouda, P.A., Kiba, K.A., Traoré, S., Soudré, F., Kouraogo, A., Karfo, R., Kabré, E., et al. (2024) Statut en magnésium et équilibre glycémique des patients diabétiques de type 2 (dt2) suivis en milieu hospitalier au Burkina Faso. Dakar Médical, 68, 21-27. https://dakarmedical.org/dkmed/index.php/dakarmed/article/view/120
|
|
[144]
|
Heroual, K., Filali, S. and Meguellati, S. (2020) Polyphenols: Structure, Antioxidant Power, and in Vitro Methods for Evaluating Antioxidant Activity. Master’s Thesis, University of Constantine 1.
|
|
[145]
|
Nève, J. (2002) Modulation de l’apport alimentaire en anti-oxydants. Nutrition Clinique et Métabolisme, 16, 292-300.[CrossRef]
|
|
[146]
|
Benkhalfoun, H. and Sour, K.N. (2022) Effect of Vitamins C and D on the Modulation of Inflammation and Oxidative Stress during Type 2 Diabetes. Master’s Thesis, Abou Bekr Belkaïd University.
|
|
[147]
|
Kaur, B. and Henry, J. (2014) Micronutrient Status in Type 2 Diabetes. In: Advances in Food and Nutrition Research, Elsevier, 55-100.[CrossRef] [PubMed]
|
|
[148]
|
Phan, O. and Burnier, M. (2007) Vitamine D et hypertension: Quel lien? Revue Médicale Suisse, 3, 2022-2026.[CrossRef]
|
|
[149]
|
Fokou, É., Ponka, R., Sielinou-Tchegnimba, A., Ngu, B. and Mbiapo Tchouanguep, F. (2008) Alimentation et statut en deux micronutriments antioxydants (Zinc et vitamine C) de quelques patients camerounais hypertendus. Nutrition Clinique et Métabolisme, 22, 4-9.[CrossRef]
|
|
[150]
|
Bonnefont-Rousselot, D. (2012) Micronutriments et risque cardiovasculaire. Nutrition Clinique et Métabolisme, 26, 14-21.[CrossRef]
|
|
[151]
|
Afkhami-Ardekani, M. and Shojaoddiny-Ardekani, A. (2007) Effect of Vitamin C on Blood Glucose, Serum Lipids & Serum Insulin in Type 2 Diabetes Patients. Indian Journal of Medical Research, 126, 471-474. https://www.ovid.com/jnls/ijmr/fulltext/02223309-200726050-00012~effect-of-vitamin-c-on-blood-glucose-serum-lipids-serum
|
|
[152]
|
Ahlam, D. and Amani, L. (2024) Bibliographical Study on Dietary Polyphenols. Master’s Thesis, Mohamed El Bachir El Ibrahimi University.
|
|
[153]
|
Post, R.E., Mainous, A.G., King, D.E. and Simpson, K.N. (2012) Dietary Fiber for the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis. The Journal of the American Board of Family Medicine, 25, 16-23.[CrossRef] [PubMed]
|
|
[154]
|
Chandalia, M., Garg, A., Lutjohann, D., von Bergmann, K., Grundy, S.M. and Brinkley, L.J. (2000) Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus. New England Journal of Medicine, 342, 1392-1398.[CrossRef] [PubMed]
|
|
[155]
|
McRae, M.P. (2018) Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-Analyses. Journal of Chiropractic Medicine, 17, 44-53.[CrossRef] [PubMed]
|
|
[156]
|
Weickert, M.O. and Pfeiffer, A.F. (2018) Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes. The Journal of Nutrition, 148, 7-12.[CrossRef] [PubMed]
|
|
[157]
|
Chen, X., Tao, L. and Wang, Y. (2025) Association of Dietary Fiber Intake with All-Cause and Cardiovascular Mortality in Diabetes and Prediabetes. Diabetology & Metabolic Syndrome, 17, 1-9.[CrossRef] [PubMed]
|
|
[158]
|
Hermansen, K. (2000) Diet, Blood Pressure and Hypertension. British Journal of Nutrition, 83, S113-S119.[CrossRef] [PubMed]
|
|
[159]
|
Sosner, P., Gremeaux, V., Bosquet, L. and Herpin, D. (2014) Hypertension artérielle et exercice physique—Mise au point pratique. Annales de Cardiologie et d’Angéiologie, 63, 197-203.[CrossRef] [PubMed]
|
|
[160]
|
Blain, H., Vuillemin, A., Blain, A. and Jeandel, C. (2000) The Preventive Effects of Physical Activity in the Elderly. La Presse Médicale, 29, 1240-1248.
|
|
[161]
|
Howard, A.A., Arnsten, J.H. and Gourevitch, M.N. (2004) Effect of Alcohol Consumption on Diabetes Mellitus. Annals of Internal Medicine, 140, 211-219.[CrossRef] [PubMed]
|
|
[162]
|
Ahmed, A.T., Karter, A.J., Warton, E.M., Doan, J.U. and Weisner, C.M. (2008) The Relationship between Alcohol Consumption and Glycemic Control among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry. Journal of General Internal Medicine, 23, 275-282.[CrossRef] [PubMed]
|
|
[163]
|
Naassïla, M. (2019) Quels bénéfices des défis “sans alcool”? Alcoologie et Addictologie, 41, 297-307. https://hal.science/hal-04319717
|
|
[164]
|
Xin, X., He, J., Frontini, M.G., Ogden, L.G., Motsamai, O.I. and Whelton, P.K. (2001) Effects of Alcohol Reduction on Blood Pressure. Hypertension, 38, 1112-1117.[CrossRef] [PubMed]
|
|
[165]
|
Roerecke, M., Kaczorowski, J., Tobe, S.W., Gmel, G., Hasan, O.S.M. and Rehm, J. (2017) The Effect of a Reduction in Alcohol Consumption on Blood Pressure: A Systematic Review and Meta-Analysis. The Lancet Public Health, 2, e108-e120.[CrossRef] [PubMed]
|
|
[166]
|
Tramunt, B. and Durlach, V. (2023) Sevrage tabagique et diabète: Quels bénéfices pour quels risques? Médecine des Maladies Métaboliques, 17, 125-131.[CrossRef]
|
|
[167]
|
Critichley, J.A. and Capewell, S. (2007) Benefits of Smoking Cessation. Current Cardiovascular Risk Reports, 1, 360-365.[CrossRef]
|
|
[168]
|
Eliasson, B., Attvall, S., Taskinen, M. and Smith, U. (1997) Smoking Cessation Improves Insulin Sensitivity in Healthy Middle‐Aged Men. European Journal of Clinical Investigation, 27, 450-456.[CrossRef] [PubMed]
|
|
[169]
|
Ohkuma, T., Iwase, M., Fujii, H., Kaizu, S., Ide, H., Jodai, T., et al. (2015) Dose-and Time-Dependent Association of Smoking and Its Cessation with Glycemic Control and Insulin Resistance in Male Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry. PLOS ONE, 10, e0122023.[CrossRef] [PubMed]
|
|
[170]
|
Durlach, V., Vergès, B., Al-Salameh, A., Bahougne, T., Benzerouk, F., Berlin, I., et al. (2022) Smoking and Diabetes Interplay: A Comprehensive Review and Joint Statement. Diabetes & Metabolism, 48, Article 101370.[CrossRef] [PubMed]
|
|
[171]
|
Tsai, S., Huang, W., Chan, H. and Hwang, L. (2021) The Role of Smoking Cessation Programs in Lowering Blood Pressure: A Retrospective Cohort Study. Tobacco Induced Diseases, 19, 1-9.[CrossRef] [PubMed]
|
|
[172]
|
Gaya, P.V., Fonseca, G.W.P., Tanji, L.T., Abe, T.O., Alves, M.J.N.N., de Lima Santos, P.C.J., et al. (2024) Smoking Cessation Decreases Arterial Blood Pressure in Hypertensive Smokers: A Subgroup Analysis of the Randomized Controlled Trial Gentsmoking. Tobacco Induced Diseases, 22, 1-10.[CrossRef] [PubMed]
|